News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs
Cell and Gene Therapy Catapult (CGT Catapult) says that GSK will leverage its Stevenage facility to perform GMP cell processing and accelerate its cell and gene therapy pipeline for clinical trials.
AstraZeneca CEO, Pascal Soriot, has said 'there is absolutely no secondary market' in vaccines against COVID-19 amid rumors of broker activity.
As more countries temporarily pause the use of the COVID-19 Vaccine AstraZeneca in their vaccination programs, the company stressed the safety of the jab, based on scientific evidence.
Guest Article
mRNA technology enabled rapid SARS-CoV-2 vaccine development. How can the biopharmaceutical industry improve before the next pandemic?